BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32127398)

  • 1. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma
    Arthur RS; Xue X; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1058-1066. PubMed ID: 32127398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and sex hormone-binding globulin with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Arthur RS; Dannenberg AJ; Rohan TE
    Int J Cancer; 2021 Jul; 149(1):42-57. PubMed ID: 33567105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-diagnostic sex hormone levels and survival among breast cancer patients.
    Kensler KH; Eliassen AH; Rosner BA; Hankinson SE; Brown M; Tamimi RM
    Breast Cancer Res Treat; 2019 Apr; 174(3):749-758. PubMed ID: 30604001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
    Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
    Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
    Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
    Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
    Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
    Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
    Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
    Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol Intake and Endogenous Hormones in Pre- and Postmenopausal Women: Findings from the UK Biobank.
    Tin Tin S; Key TJ; Reeves GK
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2294-2301. PubMed ID: 34607837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations Study.
    Schoemaker MJ; Folkerd EJ; Jones ME; Rae M; Allen S; Ashworth A; Dowsett M; Swerdlow AJ
    Br J Cancer; 2014 Apr; 110(7):1898-907. PubMed ID: 24518596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
    Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
    Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study.
    Chan MF; Dowsett M; Folkerd E; Bingham S; Wareham N; Luben R; Welch A; Khaw KT
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):900-5. PubMed ID: 17507613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
    Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
    Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
    Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
    J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.